skip to content

Department of Chemical Engineering and Biotechnology

 

Biography

07/2015: University Lecturer at the Dept. of Chemical Engineering and Biotechnology, University of Cambridge and head of the Molecular Neuroscience Group

2004-2004: Scientific Consultant for Zyentia Ltd., Cambridge, UK

2000-2002: Scientific Consultant for Lundbeck/AS, Denmark

06/1999: PhD in Medicine, Dept. of Physiological Sciences, Lund University, Sweden

05/1996: MSc in Biology at the Universite de Fribourg, Switzerland

Publications

Key publications: 

Murakami T, Qamar S, Lin JQ, Kaminski Schierle GS, Rees E, Miyashita A,  Costa AR, Dodd RB, Chan FTS, Michel CH,  Kronenberg-Versteeg D, Li Y, Yang S-P,  Wakutani Y, Meadows W, Ferry RR, Dong L,  Tartaglia GG, Favrin G,  Lin W-L,  Dickson DW,  Zhen M,  Ron D,  Schmitt-Ulms G,  Fraser PE,  Shneider NA,  Holt C,  Vendruscolo M, Kaminski CF,  George-Hyslop P.St., "ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function", Neuron (2015). doi:10.1016/j.neuron.2015.10.030

Michel CH, Kumar S, Pinotsi D, Tunnacliffe A, St George-Hyslop P, Mandelkow E, Mandelkow E-M, Kaminski CF, Kaminski Schierle GS, "Extracellular monomeric tau is sufficient to initiate the spread of Tau pathology", J. Biol. Chem. (2014), 289: 956-967. doi:10.1074/jbc.M113.515445

Kaminski Schierle GS, van de Linde S, Erdelyi M, Esbjörner EK, Klein T, Rees E, Bertoncini CW, Dobson CM, Sauer M, and Kaminski CF, "In Situ Measurements of the Formation and Morphology of Intracellular ß-Amyloid Fibrils by Super-Resolution Fluorescence Imaging", J. Am. Chem. Soc., 133 (33), pp 12902–12905, (2011). 10.1021/ja201651w

Schierle GS, Hansson O, Leist M, Nicotera P, Widner H, Brundin P (1999), “Caspase inhibition reduces apoptosis and increases survival of nigral transplants.” Nat Med 5(1):97-100. doi:10.1038/4785

Lecturer in Molecular Biotechnology
Doctor Gabriele S Kaminski Schierle

Affiliations